Case Studies from across the Catapults
- Skills (11),
- Regional growth (18),
- Highlights (27),
- Equality, Diversity and Inclusion (12),
- International (12),
- Academic engagement (19),
- Net Zero (23),
- Health (19),
- Digital technologies (19),
- Business growth (29),
- Supply chains (6),
- Leveraging Investment (19),
Themes (Reset)
- Cross-Catapult (2),
- Cell and Gene Therapy (16),
- Compound Semiconductor Applications (13),
- Connected Places (14),
- Digital (14),
- Energy Systems (14),
- High Value Manufacturing (17),
- Medicines Discovery (15),
- Offshore Renewable Energy (14),
- Satellite Applications (14),
Catapults (Reset)
Cell and Gene Therapy
Case Study
Growing new capabilities with German company Rentschler Biopharma SE
Cell and Gene Therapy Catapult partnered with German based Rentschler Biopharma to enable the establishment of new ATMP development and manufacturing capabilities in the UK, to benefit the UK and international demand and further strengthen the UK ecosystem and international supply chain.
Cell and Gene Therapy
Case Study
Advancing acute myeloid leukaemia cell therapy
A collaboration between the Cell and Gene Therapy Catapult, University College London and Imperial College London advances a novel cell therapy for the treatment of acute myeloid leukaemia.
Cell and Gene Therapy
Case Study
Developing treatments for chronic kidney disease
University spin-out Purespring Therapeutics sought expert input from the Cell and Gene Therapy Catapult to efficiently progress their pre-clinical development plans and secured one of the largest single investment to a UK biotech company from global healthcare giant Syncona.
Cell and Gene Therapy
Case Study
Pioneering technology to increase effectiveness of gene therapeutics
A collaboration between the Cell and Gene Therapy Catapult and Synpromics set out to develop novel scalable manufacturing processes and technologies to produce viral vectors at scale.
Page 1 of 1